Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP651148.RAAWGC6k6Vqdd7IuxzNLqoFrCmteIIAo6m4Bo6NMVzxCs130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651148.RAAWGC6k6Vqdd7IuxzNLqoFrCmteIIAo6m4Bo6NMVzxCs130_provenance.
• NP309406.RA8g1-wakjP_NXZKyrdvS6yOYHfE823B-Lanh6FQICBcg130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309406.RA8g1-wakjP_NXZKyrdvS6yOYHfE823B-Lanh6FQICBcg130_provenance.
• NP312184.RA7IoUnKGJiOn7_Tk3bI1DkY85hYyBJ6JepeVK7-zSOoQ130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312184.RA7IoUnKGJiOn7_Tk3bI1DkY85hYyBJ6JepeVK7-zSOoQ130_provenance.
• NP312355.RA4R7qnOjKRrUW0JRpAfV5u98Tf86MnXYplQP8N6Tulk8130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312355.RA4R7qnOjKRrUW0JRpAfV5u98Tf86MnXYplQP8N6Tulk8130_provenance.
• NP309005.RAZhMXSHQQUmnMV7RxnfjW3b_uEX_SAGX4PPgX_JqZMEc130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309005.RAZhMXSHQQUmnMV7RxnfjW3b_uEX_SAGX4PPgX_JqZMEc130_provenance.
• NP900951.RADcRj4esSiLFZjuM2luAmXwGYgelZxi1Y4CNYS8EXO4A130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900951.RADcRj4esSiLFZjuM2luAmXwGYgelZxi1Y4CNYS8EXO4A130_provenance.
• NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900943.RAz_VrRZq6M3-D72f0jM6KdGnDLzxunEK_Png1cgLQj9M130_provenance.
• NP900946.RAzKBiwD8Ba6CvOnUBXN2mX77w7S-3QB3zK1X9HNTRTZE130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900946.RAzKBiwD8Ba6CvOnUBXN2mX77w7S-3QB3zK1X9HNTRTZE130_provenance.
• NP900949.RA4TJOu3XjO96CBsyPAbK-i01deMLyIjdX0-UaxedUinY130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900949.RA4TJOu3XjO96CBsyPAbK-i01deMLyIjdX0-UaxedUinY130_provenance.
• NP900955.RAwXlWbUyLKitUrgCKIRTkKmGTkf7dAsgT-JFi56IDhM4130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900955.RAwXlWbUyLKitUrgCKIRTkKmGTkf7dAsgT-JFi56IDhM4130_provenance.
• NP900941.RAf0EXoh46q3cCHVh58s65t32m2ATAFk5WDEInazeraU8130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900941.RAf0EXoh46q3cCHVh58s65t32m2ATAFk5WDEInazeraU8130_provenance.
• NP900947.RAX22zDrmeQhrsKY34AkJeWKqsUc_DatS_vTtiQ7oeKzM130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900947.RAX22zDrmeQhrsKY34AkJeWKqsUc_DatS_vTtiQ7oeKzM130_provenance.
• NP900950.RAVtKb4zk9VTGbLPQnpWwGQ1ETFIaQ8Ty1Hm9H9mmMvKI130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900950.RAVtKb4zk9VTGbLPQnpWwGQ1ETFIaQ8Ty1Hm9H9mmMvKI130_provenance.
• NP900959.RATeH9ajgatkz3l7OamFUky0RQEmUdhDiRPYLoG6wn6FM130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900959.RATeH9ajgatkz3l7OamFUky0RQEmUdhDiRPYLoG6wn6FM130_provenance.
• NP651320.RANw6ERpTqgqiEE3ZILqFSZmPOd6aKwT0XH5NU3qpjlKM130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651320.RANw6ERpTqgqiEE3ZILqFSZmPOd6aKwT0XH5NU3qpjlKM130_provenance.
• NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_provenance.
• NP312072.RAsIpI_VNziPiC1DUbHH77rwfJ9Zcb34KdMewG-qMpzWs130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312072.RAsIpI_VNziPiC1DUbHH77rwfJ9Zcb34KdMewG-qMpzWs130_provenance.
• NP900957.RAp_upJdiODw6J8srdmcGjKF05UIkFptpji1sA5SxAVSo130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900957.RAp_upJdiODw6J8srdmcGjKF05UIkFptpji1sA5SxAVSo130_provenance.